Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Infographic
Financial Services
DeciBio’s Insights From #JPM23
We had over 50 meetings with companies and investors across sequencing, spatial and single cell, pharma and biotech, core diagnostics, and liquid biopsy players at #JPM2023.
January 16, 2023
Infographic
Financial Services
DeciBio’s Insights From #JPM23
We had over 50 meetings with companies and investors across sequencing, spatial and single cell, pharma and biotech, core diagnostics, and liquid biopsy players at #JPM2023.
January 16, 2023
Next-Generation Therapeutics
Precision Medicine
Cell & Gene Tx
Digital Health
Immuno-Oncology
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | December Roundup
Liquid Biopsy (LBx) had an active December, featuring distribution deals and debuted products as well as many trial and study results.
January 11, 2023
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | December Roundup
Liquid Biopsy (LBx) had an active December, featuring distribution deals and debuted products as well as many trial and study results.
January 11, 2023
Liquid Biopsy
DeciBio Q&A
Pharma & Biotech
Women’s Health Today and Tomorrow: DeciBio's Q&A with Fanny Anderson, Global Market Development Manager at Illumina
Read our latest Q&A with Fanny Anderson, Senior Global Market Development Manager at Illumina.
January 10, 2023
DeciBio Q&A
Pharma & Biotech
Women’s Health Today and Tomorrow: DeciBio's Q&A with Fanny Anderson, Global Market Development Manager at Illumina
Read our latest Q&A with Fanny Anderson, Senior Global Market Development Manager at Illumina.
January 10, 2023
Women's Health
Blog Article
Pharma & Biotech
The Future of Human Ex-Vivo Assays: DeciBio Q&A with Jan Lichtenberg of InSphero
Check out our latest Q&A with Lichtenberg, CEO of InSphero, to understand how changing market dynamics are enabling broader adoption of human in vitro assays.
January 6, 2023
Blog Article
Pharma & Biotech
The Future of Human Ex-Vivo Assays: DeciBio Q&A with Jan Lichtenberg of InSphero
Check out our latest Q&A with Lichtenberg, CEO of InSphero, to understand how changing market dynamics are enabling broader adoption of human in vitro assays.
January 6, 2023
No items found.
Blog Article
Pharma & Biotech
CGT in 2023 – Predictions on the Road Ahead for a Maturing Field
Our cell and gene therapy practice experts highlight their predictions for the field in 2023.
January 4, 2023
Blog Article
Pharma & Biotech
CGT in 2023 – Predictions on the Road Ahead for a Maturing Field
Our cell and gene therapy practice experts highlight their predictions for the field in 2023.
January 4, 2023
Life Science Consulting
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | December Roundup
A number of key developments occurred during the last month of 2022 in Next-Generation Therapeutics
December 22, 2022
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | December Roundup
A number of key developments occurred during the last month of 2022 in Next-Generation Therapeutics
December 22, 2022
Next-Generation Therapeutics
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved